United States
Securities and Exchange Commission
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 5, 2010
Prospect Medical Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-32203 |
|
33-0564370 |
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
10780 Santa Monica Blvd., Suite 400 |
|
|
Los Angeles, California |
|
90025 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (310) 943-4500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07 Submission of Matters to a Vote of Security Holders.
The annual meeting of stockholders of Prospect Medical Holdings, Inc. (we, us, our, or the Company) was held on March 5, 2010. The stockholders considered three proposals, each of which is described in more detail in our definitive proxy statement dated February 8, 2010.
Proposal 1: Approval of a proposal to amend our Certificate of Incorporation to provide for a classified Board of Directors.
FOR |
|
AGAINST |
|
ABSTAIN |
|
15,021,113 |
|
3,127,180 |
|
27,221 |
|
Broker Non-Votes: 0
The foregoing proposal was approved by affirmative vote of a majority of the 20,792,520 shares of our common stock outstanding as of the record date for the Annual Meeting.
Proposal 2: Election of five directors to hold office, subject to the approval of Proposal 1, above, until the Annual Meeting for the year, indicated below, in which such Class of directors expires:
|
|
Class |
|
FOR |
|
WITHHELD |
|
Samuel S. Lee |
|
2013 |
|
9,591,958 |
|
435,931 |
|
David Levinsohn |
|
2011 |
|
9,593,325 |
|
434,564 |
|
Jeereddi Prasad, M.D. |
|
2012 |
|
9,592,287 |
|
435,602 |
|
Glenn R. Robson |
|
2012 |
|
9,593,465 |
|
434,424 |
|
Kenneth Schwartz |
|
2011 |
|
9,593,465 |
|
434,424 |
|
Broker Non-Votes: 0
All of the foregoing candidates were elected by affirmative vote of a majority of the shares voted at the Annual Meeting.
Proposal 3: Ratification of the selection of BDO Seidman, LLP as our independent public accountant for the fiscal year ending September 30, 2010:
FOR |
|
AGAINST |
|
ABSTAIN |
|
13,266,470 |
|
26,278 |
|
2,000 |
|
Broker Non-Votes: 0
The foregoing proposal was approved by affirmative vote of a majority of the shares voted at the Annual Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
PROSPECT MEDICAL HOLDINGS, INC. |
|
|
|
|
|
|
|
|
By: |
/s/ MIKE HEATHER |
|
|
Mike Heather |
|
|
Chief Financial Officer |
Dated: March 10, 2010